Amylyx’s mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, Amylyx sees opportunities and pursues them with urgency, rigorous science, and unwavering commitment to the communities it serves. Amylyx is currently focused on four investigational therapies across several endocrine conditions and neurodegenerative diseases in which it believes it can make the greatest impact.
Products & Services Offered
Investigational therapies in Post-Bariatric Hypoglycemia, Congenital Hyperinsulinism, Wolfram Syndrome, and Amyotrophic Lateral Sclerosis
Category
Pharmaceutical Manufacturing
Contact Information
Siobhan Fitzgerald
Patient and Professional Advocacy
siobhan_fitzgerald@amylyx.com